We evaluated the effect of Saccharomyces boulardii administration in otherwise healthy children aged between 6 months and 10 years who were admitted for acute diarrhoea (15 males, 12 females). The patients were randomized into two groups: group 1 (n = 16) received 250 mg S. boulardii dissolved in 5 ml of water orally twice daily for 7 days and group 2 (n = 11) received placebo. Clinical and laboratory assessments were performed on admission and on day 7 of follow-up. Both groups experienced reduced daily stool frequency, the decrease being significantly greater in group 1 on days 3 and 4 compared with group 2. Group 1 demonstrated significant increases in serum immunoglobulin A and decreases in C-reactive protein levels on day 7. The percentage of CD8 lymphocytes on day 7 was significantly higher in group 1 than group 2. This study confirmed the efficacy of S. boulardii in paediatric acute gastroenteritis and the findings suggest that S. boulardii treatment enhances the immune response.
SzajewskaHSettyMMrukowiczJGuandaliniS: Probiotics in gastrointestinal diseases in children: Hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr2006; 42: 454–475.
7.
OberhelmanRAGilmanRHSheenPTaylorDNBlackRECabreraL: A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr1999; 134: 15–20.
8.
GuandaliniSPensabeneLZikriMADiasJACasaliLGHoekstraH: Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr2000; 30: 54–60.
9.
MarteauPRde VreseMCellierCJSchrezenmeirJ: Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr2001; 73: 430S–436S.
10.
ChapoyP: Treatment of acute infantile diarrhea: Controlled trial of Saccharomyces boulardii.Ann Pediatr1985; 32: 561–563.
11.
Cetina-SauriGCSierraG Basto: Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhaea. Ann Pediatr1994; 41: 397–400.
12.
UrganciNPolatTUysalMCetinkayaF: Evaluation of the efficacy of Saccharomyces boulardii in children with acute diarrhea. Arch Gastroenterohepatol2001; 20: 1–6.
13.
KurugölZKoturoğluG: Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Pediatr2005; 94: 44–77.
14.
McFarlandLVSurawiczCMGreenbergRNElmerGWMoyerKAMelcherSA: Prevention of beta-lactam associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol1995; 90: 439–448.
15.
McFarlandLVSurawiczCMGreenbergRNFeketyRElmerGWMoyerKA: A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA1994; 271: 1913–1918.
16.
SurawiczCMMcFarlandLVGreenbergRNRubinMFeketyRMulliganME: The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.Clin Infect Dis2000; 31: 1012–1017.
17.
SurawiczCMElmerGWSpeelmanPMcFarlandLVChinnJVan BelleG: Prevention of antibiotic associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology1989; 96: 981–988.
18.
D'SouzaALRajkumarCCookeJBulpittCJ: Probiotics in prevention of antibiotic associated diarrhoea: Meta-analysis. BMJ2002; 324:1361.
19.
KotowskaMAlbrechtPSzajewskaH: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther2005; 21: 583–590.
20.
SzajewskaHMrukowiczJ: Meta-analysis: Non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther2005; 22: 365–372.
21.
QamarAAboudolaSWarnyMMichettiPPothoulakisCLaMontJT: Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect Immun2001; 69: 2762–2765.
22.
JahnHUUllrichRSchneiderTLiehrRMSchieferdeckerHLHolstH: Immunological and trophical effects of Saccharomyces boulardii on the small intestine in healthy human volunteers. Digestion1996; 57: 95–104.
23.
IsolauriEArvolaTSutasYMoilanenESalminerS: Probiotics in the management of atopic eczema. Clin Exp Allergy2000; 30: 1604–1610.
24.
KalliomakiMSalimnenSArvilommiHKeroPKoskinenPIsolauriE: Probiotics in primary prevention of atopic disease: A randomised placebo controlled trial. Lancet2001; 357: 1076–1079.
25.
HartALLammersKBrigidiPVitaliBRizzelloFGionchettiP: Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut2004; 53: 1602–1609.
26.
MohamadzadehMOlsonSKalinaWVRuthelGDemminGLWarfieldKL: Lactobacilli activate human dendritic cells that show T cells towards T helper I polarization. Proc Natl Acad Sci USA2005; 102: 2880–2885.
27.
VaoralaO: Immunological effects of probiotics with special reference to lactobacilli. Clin Exp Allergy2003; 33: 1634–1640.
28.
von der WeidTBulliardCSchiffrinEJ: Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity produce transforming growth factor beta and interleukin-10. Clin Diagn Lab Immunol2001; 8: 695–701.
29.
BorruelNCarolMCasellasFAntolinMde LaraFEspinE: Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut2002; 51: 659–664.
30.
RodriguesACCaraDCFretezSHCunhaFQVieiraECNicoliJR: Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol2000; 89: 404–414.
31.
CaetanoJAParamesMTBaboMJ: Immunopharmacological effects of Saccharomyces boulardii in healthy human volunteers. Int J Immunopharmacol1986; 8: 245–259.
32.
TarcanAGürakenFTikerFÖzbekN: Influence of feeding formula and breast milk fortifier on lymphocyte subsets in very low birth weight premature newborns. Biol Neonate2004; 86: 22–28.
33.
HawkesJSNeumannMAGibsonRA: The effects of breast feeding on lymphocyte subpopulations in healthy term infants at 6 months of age. Pediatr Res1999; 45: 648–651.
34.
RinneMKalliomakiMSalminenSIsolauriE: Probiotic intervention in the first months of life: Short-term effects on gastrointestinal symptoms and long-term effects on gut microbiota. J Pediatr Gastroenterol Nutr2006; 43: 200–205.
